Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 720 Thousand USD | -66.54% |
| 2022 | 2.15 Million USD | -71.64% |
| 2021 | 7.58 Million USD | -77.58% |
| 2020 | 33.84 Million USD | 0.34% |
| 2019 | 33.72 Million USD | 137.37% |
| 2018 | 14.2 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | 1.63 Million USD | -23.84% |
| 2023 FY | 720 Thousand USD | -66.54% |
| 2023 Q2 | 1.29 Million USD | -20.87% |
| 2023 Q3 | 1.22 Million USD | -5.55% |
| 2023 Q4 | 720 Thousand USD | -41.22% |
| 2022 FY | 2.15 Million USD | -71.64% |
| 2022 Q4 | 2.15 Million USD | -26.33% |
| 2022 Q3 | 2.92 Million USD | -15.77% |
| 2022 Q2 | 3.46 Million USD | -58.79% |
| 2022 Q1 | 8.41 Million USD | 10.93% |
| 2021 Q2 | 6.55 Million USD | -81.36% |
| 2021 Q1 | 35.19 Million USD | 3.98% |
| 2021 FY | 7.58 Million USD | -77.58% |
| 2021 Q4 | 7.58 Million USD | -41.98% |
| 2021 Q3 | 13.07 Million USD | 99.37% |
| 2020 Q4 | 33.84 Million USD | -13.54% |
| 2020 FY | 33.84 Million USD | 0.34% |
| 2020 Q3 | 39.14 Million USD | 13.32% |
| 2020 Q2 | 34.54 Million USD | 1.46% |
| 2020 Q1 | 34.04 Million USD | 0.94% |
| 2019 Q4 | 33.72 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 33.72 Million USD | 137.37% |
| 2018 FY | 14.2 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Bright Green Corporation | 201.78 Thousand USD | -256.819% |
| BioQuest Corp. | - USD | -Infinity% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 98.719% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| GSRX Industries Inc. | - USD | -Infinity% |
| High Sierra Technologies, Inc. | 50 Thousand USD | -1340.0% |
| Instadose Pharma Corp. | - USD | -Infinity% |